BioVie Inc. Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net
BioVie Inc. (BIVI) reported Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net of $406.83 thousand for the 9-month period ending 2013-12-31, per its 10-Q filed 2014-01-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet · last filed 2014-01-29
- 2013-12-31: Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 6 month -$98.87K; Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 9 month $406.83K.
| Period end | Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 9 month |
|---|---|---|
| 2013-12-31 | -$98.87K 10-Q · filed 2014-01-29 | $406.83K 10-Q · filed 2014-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |